CASI Pharmaceuticals Funding & Investors
Rockville, MD
A biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients.
casipharmaceuticals.comTotal Amount Raised: $185,380,000
CASI Pharmaceuticals Funding Rounds
Post Ipo Equity
$32,500,000
Post Ipo Equity
$38,000,000
Post Ipo Equity
$50,000,000
Post Ipo Equity Investors
IDG CapitalETP FundRobert DugganPost Ipo Equity
$2,380,000
Post Ipo Equity
$10,000,000
Post Ipo Equity Investors
Accel PartnersEmerging Technology PartnersPost Ipo Equity
$2,500,000
Post Ipo Debt
$20,000,000
Post Ipo Debt Investors
GE HealthcareMerrill LynchOxford FinancePost Ipo Equity
$30,000,000
IPO
Unknown
Funding info provided by Diffbot.